Cornea, cataract, refractive, and anterior segment surgery remain at the forefront of ophthalmic innovation, yet several challenges persist that demand critical reflection and collaborative solutions. As we navigate 2025, a few key issues warrant our attention.
Clinical Report: A Transformative Period in Cornea and Anterior Segment Surgery
Overview
This report highlights the evolving landscape of corneal transplantation, keratoconus management, and ocular surface disease, emphasizing the need for standardization and improved accessibility. Innovations in technology and treatment protocols are crucial for enhancing patient outcomes in these areas.
Background
Corneal and anterior segment disorders are significant contributors to visual impairment globally, necessitating ongoing advancements in surgical techniques and management strategies. The increasing prevalence of ocular surface diseases, particularly in the context of modern lifestyle factors, underscores the importance of timely diagnosis and effective treatment. As the field evolves, addressing disparities in access to care and integrating new technologies into practice are critical for improving patient outcomes.
Data Highlights
No numerical data available in the source material.
Key Findings
Corneal transplantation techniques like DMEK and DALK are gaining global traction but face accessibility challenges.
Keratoconus management is evolving with corneal cross-linking, yet standardization in treatment protocols is needed, especially for pediatric patients.
Ocular surface disease is increasingly recognized as a public health issue, with research into inflammatory pathways and the microbiome paving the way for targeted therapies.
Integration of artificial intelligence in corneal topography is limited by cost and training gaps.
Clinicians face pressures from declining reimbursements and patient expectations, impacting timely access to care.
Clinical Implications
Healthcare professionals must prioritize the adoption of innovative techniques and standardized protocols to enhance patient care in corneal and anterior segment disorders. Additionally, addressing the challenges of accessibility and integrating new diagnostic technologies will be essential for improving treatment outcomes.
Conclusion
The current transformative period in corneal and anterior segment surgery presents both challenges and opportunities for clinicians. Emphasizing collaboration and innovation will be key to advancing care in this dynamic field.
This article will examine the indications, clinical evidence, and practical considerations for managing severe ocular surface disease and inflammatory dry eye using scleral lenses, and offer guidance to practitioners who seek to expand their therapeutic options.
